IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of "Reduce" From Analysts
Summary by marketbeat.com
2 Articles
2 Articles
All
Left
Center
1
Right
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of "Reduce" from Analysts
IGM Biosciences, Inc. (NASDAQ:IGMS - Get Free Report) has been assigned a consensus rating of "Reduce" from the ten analysts that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation and nine have issued a hold recommendation on
Fortis Inc. (NYSE:FTS) Receives Average Rating of “Reduce” from Analysts
Shares of Fortis Inc. (NYSE:FTS – Get Free Report) have been assigned an average recommendation of “Reduce” from the six ratings firms that are presently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation and four have issued a hold recommendation on the company. The average 12 […]
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage